Your email has been successfully added to our mailing list.

×
0.00943396226415095 0.0274528301886792 0.00476415094339622 0.0136792452830188 0.0283018867924529 0.0188679245283019 0.0141509433962263 0.0188679245283019
Stock impact report

Celsion Announces ThermoDox® HEAT Study Presentation at Korean Liver Cancer Association’s 12th Annual Scientific Meeting

Celsion Corporation (CLSN) 
Last celsion corporation earnings: 11/14 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.celsion.com/investor-relations
Company Research Source: GlobeNewswire
LAWRENCEVILLE, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation today announced that an abstract discussing the Company’s Phase III HEAT study evaluating ThermoDox® in combination with radiofrequency ablation (RFA) was one of six selected for presentation as part of the lecture of the Presidential Selection at the Korean Liver Cancer Association’s 12th Annual Scientific Meeting in Seoul, South Korea. ThermoDox® is Celsion’s proprietary, heat-activated liposomal encapsulation of doxorubicin for the treatment of primary liver cancer, also known as hepatocellular carcinoma, or HCC. The presentation was given on February 9, 2018, by Won Young Tak, M.D., Ph.D., Professor Internal Medicine, Gastroenterology & Hepatology, Kyungpook National University Hospital Daegu, Republic of Korea, and a lead investigator for the HEAT Study and the Company’s ongoing second Phase III study of ThermoDox® in combination with RFA, the OPTIMA Study. “RFA duration appears to be a cr Show less Read more
Impact Snapshot
Event Time:
CLSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLSN alerts
Opt-in for
CLSN alerts

from News Quantified
Opt-in for
CLSN alerts

from News Quantified